Achievement
year
Authors
Language
Paper Title
Chang CY, Hung GU, Hsu BL, Yang BH, Chang CW, Hu LH, Huang WS, Wang HE, Wu TC, Liu RS*.
J Nucl Cardiol 2020;27:819-28. (IF: 3.366)
Simplified quantification of (13) N-ammonia PET myocardial blood flow: A comparative study with the standard compartment model to facilitate clinical use.
Chang HC, Cheng HM, Huang WM, Lee CW, Guo CY, Yu WC, Chen CH, Sung SH.*
J Chin Med Assoc 2020;83:544-50. (IF: 2.170)
Risk stratification in patients hospitalized for acute heart failure in Asian population.
Chang HC, Huang CJ, Cheng HM, Yu WC, Chiang CE, Sung SH*, Chen CH*.
ESC Heart Fail 2020;7:2807-17. (IF: 3.902)
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure.
Chang HH, Chen PL, Leu HB, Chen IM, Wu NY, Chen YH*.
BMC Cardiovasc Disord 2020;20:283. (IF: 2.078)
Sex difference in the prognostic role of body composition parameters in Taiwanese patients undergoing transcatheter aortic valve implantation.
Chang JH, Cheng CC, Lu YY, Chen YC, Chen SA, Chen YJ*.
Iran J Basic Med Sci 2020;23 865-70. (IF:2.146)
Trastuzumab increases pulmonary vein arrhythmogenesis through modulating pulmonary vein electrical and conduction properties via phosphatidylinositol 3-kinase signaling.
Chang LH, Hwu CM, Lin YC, Huang CC, Won JGS, Chen HS, Lin LY*.
Endocr Pract 2020;26:1115-24. (IF: 3.869)
Soluble tumor necrosis factor receptor type 1 levels exhibit the better association with renal outcomes than traditional risk factors in Chinese subjects with type 2 diabetes mellitus.
Chang TI, Chen CH, Hsieh HL, Chen CY, Hsu SC, Cheng HS, Huang WC, Sue YM, Hsu YH, Lin FY, Shih CM, Lin SJ, Huang PH, Liu CT*.
Sci Rep 2020;10:12135. (IF: 3.998)
Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula.
Chang TT, Chen JW*.
Pharmacol Res 2020;151:104509. (IF:5.893)
Hydralazine improves ischemia-induced neovasculogenesis via xanthine-oxidase inhibition in chronic renal insufficiency.
Chang TT, Chen JW*.
Int J Mol Sci 2020;21:3172. (IF: 4.556)
The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy.
Chang TT, Yang HY, Chen C, Chen JW.
Int J Mol Sci 2020;21:6567. (IF:4.556)
CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation.